Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
408.00    1.00 (0.25%)
Bid:
403.00
Ask:
407.50
Spread: 4.50 (1.117%)
Market Cap: £141.73m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

PDMR & Director Dealings

13 Feb 2017 15:37

RNS Number : 7607W
Frontier Developments PLC
13 February 2017
Β 

13 February 2017

Β 

Frontier Developments plc

(the "Company")

Β 

PDMR & Director Dealings

Β 

The Company was notified on 13 February 2017 that Charles Cotton, non-executive director of the Company,Β acquired 20,482 Ordinary Shares in the Company on 10 February 2017 at a price of 285 pence per Ordinary Share.

Β 

Following this transaction, Charles Cotton is interested in 39,339 Ordinary Shares, representing 0.12 per cent of the Company's total issued share capital.

Β 

The Company was also notified on 13 February 2017 that on the same date, John Laws, a PDMR of the company sold 3,500 ordinary shares of 0.5p each in the Company ("Ordinary Shares") at 278 pence per share.

Β 

Β 

Enquiries:

Frontier Developments

+44 (0)1223 394 300

Β 

David Braben, CEO

David Walsh, COO

Β 

Β 

Numis - Nomad and Joint Broker

+44 (0)20 7260 1000

Β 

Simon Willis / Jamie Lillywhite (Nomad) / Toby Adcock

Β 

Β 

Finncap

+44 (0) 207 220 0500

Β 

Matt Goode / Giles Rolls

Β 

Β 

Tulchan Communications

+44 (0) 207 353 4200

Β 

James Macey White / Matt Low

Β 

About Frontier Developments plc

Frontier Developments plc, listed on the AIM stock market (AIM: FDEV), is a leading independent creator of self-published videogame franchises founded in 1994 by David Braben, co-author of the seminal 'Elite' game. Based in Cambridge, Frontier uses its proprietary 'COBRA' game development technology to create innovative games, currently focusing on videogame consoles and personal computers.

www.frontier.co.uk

Β 

Frontier Developments plc

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

Β 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Charles Cotton

2.

Reason for the notification

a)

Position/status: Non-Executive Director

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: n/a

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 0.5p each.

Identification code: GB00BBT32N39

b)

Nature of the transaction: Purchase

c)

Price(s) and volume(s):

Price(s)

Volume(s)

285p

20,482

d)

Aggregated information:

Β· Aggregated volume: 20,482

Β· Price: 285p

e)

Date of the transaction: 2017-02-10

f)

Place of the transaction: XLON

Β 

Β 

Frontier Developments plc

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

Β 

5.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: John Laws

6.

Reason for the notification

a)

Position/status: Director of Art

b)

Initial notification/Amendment: Initial Notification

7.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: n/a

8.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 0.5p each.

Identification code: GB00BBT32N39

b)

Nature of the transaction: Sale

c)

Price(s) and volume(s):

Price(s)

Volume(s)

278p

3,500

d)

Aggregated information:

Β· Aggregated volume: 3,500

Β· Price: 278p

e)

Date of the transaction: 2017-02-13

f)

Place of the transaction: XLON

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHTJMATMBJBBFR
Date   Source Headline
24th Jun 20267:00 amRNSExercise of Options, Director/PDMR Shareholding
16th Jun 20262:43 pmRNSEBT Share Purchase
15th Jun 202610:34 amRNSEBT Share Purchase
12th Jun 20262:28 pmRNSHolding(s) in Company
10th Jun 20267:00 amRNSCMS STRATEGY DELIVERS RECORD FINANCIAL RESULTS
8th Jun 20261:54 pmRNSEBT Share Purchase
1st Jun 202612:05 pmRNSEBT Share Purchase
28th May 20262:30 pmRNS-RPlanet Zoo 2 Announced
22nd May 202611:26 amRNS-RWarhammer 40,000: Chaos Gate – Deathwatch Revealed
22nd May 20269:16 amRNSHolding(s) in Company
19th May 20265:47 pmRNSHolding(s) in Company
18th May 202610:48 amRNSEBT Share Purchase
12th May 20267:00 amRNSTrading Update - FY26 Revenue & Profit Upgraded
23rd Apr 20267:00 amRNSCompletion of Share Buyback Programme
23rd Apr 20267:00 amRNSDirector/PDMR Shareholding
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 202611:05 amRNSHolding(s) in Company
22nd Apr 20267:00 amRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.